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Individual members of the E2F/DP protein family control cell cycle progression by acting predominantly as
an activator or repressor of transcription. In Drosophila melanogaster the E2f1, E2f2, Dp, and Rbf1 genes all
contribute to replication control in ovarian follicle cells, which become 16C polyploid and subsequently
undergo chorion gene amplification late in oogenesis. Mutation of E2f2, Dp, or Rbf1 causes ectopic DNA
replication throughout the follicle cell genome during gene amplification cycles. Here we show by both reverse
transcription-PCR and DNA microarray analysis that the transcripts of prereplication complex (pre-RC)
genes are elevated compared to the wild type in E2f2, Dp, and Rbf1 mutant follicle cells. For some genes the
magnitude of this transcriptional derepression is greater in Rbf1 than in E2f2 mutants. These differences
correlate with differences in the magnitude of the replication defects in follicle cells, which attain an inappro-
priate 32C DNA content in both Rbf1 and Dp mutants but not in E2f2 mutants. The ectopic genomic replication
of E2f2 mutant follicle cells can be suppressed by reducing the Orc2, Orc5, or Mcm2 gene dose by half,
indicating that small changes in pre-RC gene expression can affect DNA synthesis in these cells. We conclude
that RBF1 forms complexes with both E2F1/DP and E2F2/DP that cooperate to repress the expression of
pre-RC genes, which helps confine DNA synthesis to sites of gene amplification. In contrast, E2F1 and E2F2
repressors function redundantly for some genes in the embryo. Thus, the relative functional contributions of
E2F1 and E2F2 to gene expression and cell cycle control depends on the developmental context.
During animal development, individual cells choose differ-
ent fates based on temporal and spatial molecular cues. The
integration of these cues is essential for cells to behave in a
manner commensurate with their fate. An excellent example of
such behavior is the execution of a specialized cell cycle pro-
gram during Drosophila melanogaster oogenesis. In order to
achieve the biosynthetic capacity to rapidly synthesize a mature
egg, cells in the ovary progress through a complex cell cycle
program that includes cell division, polyploidization, and gene
amplification (26, 30, 31, 39). A Drosophila ovary contains 14 to
16 ovarioles, each of which consists of a series of connected egg
chambers at successive stages of oogenesis (37). Each egg
chamber contains a cyst of 16 germ cells, one of which becomes
the oocyte, while the rest differentiate to form polyploid nurse
cells that support oocyte growth. The germ cell cyst is encap-
sulated within a single epithelial layer of somatic follicle cells.
Follicle cells arise from two stem cells at the anterior end of
each ovariole and proliferate through six rounds of mitotic cell
division to generate this epithelium. These follicle cells subse-
quently begin endocycles through which they attain a polyploid
16C DNA content by stage 10 of oogenesis (5, 26). At this
stage, the follicle cells cease endocycling and begin synchro-
nous amplification of several distinct genomic loci, two of
which contain a cluster of chorion genes that encode eggshell
proteins. Gene amplification occurs through repeated use of
replication origins within these loci, and an ca. 80-fold ampli-
fication has been measured for the third chromosome chorion
locus (6, 29, 37). Disruption of the follicle cell cycle program,
especially chorion gene amplification, prevents proper forma-
tion of the eggshell and causes sterility (23, 24).
Transitions between different stages of the follicle cell cycle
program are under developmental control. For instance, loss
of Notch signaling in follicle cells prevents the normal transi-
tion from the mitotic cell cycle to the endocycle (10, 27).
Ecdysone signaling also contributes to the normal patterns of
endocycle S phase and gene amplification in follicle cells (43).
Insight into follicle cell cycle control has also been gained
through a genetic analysis of the cell cycle machinery. Hypo-
morphic, female sterile alleles of genes such as Orc2, Mcm6,
and chiffon (DBF4), which encode proteins required for the
initiation of DNA replication, reduce the level of chorion gene
amplification and cause production of a thin eggshell (23, 24,
36). Regulators of the initiation of DNA synthesis, such as
cyclin E/cdk2 and E2F transcription factors, also play an im-
portant role in controlling follicle cell cycles (5, 7, 32). In the
present study we examine the contribution that E2F family
members make to the transition from endocycles to chorion
gene amplification.
Functional E2F is a heterodimer consisting of a molecule of
E2F bound to a molecule of DP. E2F affects cell cycle pro-
gression by acting as both a positive and negative regulator of
the G1-to-S transition via the transcriptional control of genes
encoding replication factors, including prereplication complex
(pre-RC) components such as ORC and MCM (8, 15, 42). In
the negative role, E2F is bound to a member of the pRb family
* Corresponding author. Mailing address: Department of Biology,
CB#3280, University of North Carolina, Chapel Hill, NC 27599.
Phone: (919) 962-7749. Fax: (919) 962-8472. E-mail: duronio@med
.unc.edu.
2123
of tumor suppressors and functions in a transcriptional repres-
sor complex (2, 15, 18, 20). These complexes are the predom-
inant form of E2F in early G1 and quiescent cells (17). In the
positive role, pRb becomes phosphorylated by G1 cyclin/cdk’s
in response to proliferative signals and releases E2F/DP to act
as a transcriptional activator (15).
The relative importance of the activator versus repressor
roles for E2F in cell cycle control in vivo is unresolved (8). The
components of E2F complexes are encoded by gene families
(e.g., six E2Fs, two DPs, and three pRB family proteins are
found in mammals), leading to the hypothesis that there is
functional specialization within the E2F family. In this model,
certain E2Fs act primarily as positive regulators of the cell
cycle, while others act primarily as inhibitors (9, 17, 21, 22, 34,
45). Studies in Drosophila have provided some evidence for this
model. The Drosophila genome contains two E2Fs (E2f1 and
E2f2), a single Dp, and two pRb (Rbf1 and Rbf2) genes (15).
E2f1, Dp, and Rbf1 are each essential, whereas E2f2 is not
essential for viability but is required for normal female fertility
(7, 11, 13, 14, 16, 33). Phenotypic analysis of these mutants
suggests the possibility that E2F2/DP participates predomi-
nantly in repression, whereas E2F1/DP may be the predomi-
nant activator. Mutation of E2f2 extends the stage of develop-
ment at which E2f1-null mutants die (i.e., from larvae to
pupae), indicating that these two E2Fs functionally antagonize
one another in vivo (16).
E2F and RBF also function in the control of the follicle cell
cycle program. Viable, hypomorphic alleles of E2f1 and Dp
decrease chorion gene amplification, producing eggs with a
thin shell (32). Conversely, Rbf1 mutant follicle cells overam-
plify chorion genes (3). Interestingly, these phenotypes may be
independent of transcription because E2F1 is found at chorion
loci by chromatin immunoprecipitation experiments and E2F1,
DP, and RBF1 all coimmunoprecipitate with ORC2 from
ovary extracts (3). However, these data do not preclude a role
for transcriptional regulation by E2F complexes in other as-
pects of follicle cell cycle control. One such role may be to
prevent the inappropriate firing of nonchorion genomic origins
of replication during gene amplification. In a subset of follicle
cells in Dp, Rbf1, or E2f2 mutant egg chambers, DNA synthesis
is not restricted to sites of gene amplification but rather occurs
throughout the nucleus (3, 7, 32). Here we present molecular
and genetic evidence suggesting that E2F1/DP and E2F2/DP
cooperate in transcriptional repressor complexes with RBF1 to
reduce the expression of pre-RC genes in follicle cells, which
helps restrict DNA replication to sites of gene amplification. In
addition, our data suggest that during embryogenesis these
repressors function redundantly rather than cooperatively.
Therefore, activator and repressor roles are not always strictly
segregated between different E2F molecules in Drosophila, and
the extent to which their similar repressor functions are both
required depends on the developmental context.
MATERIALS AND METHODS
Fly stocks and genetics. The null deletion alleles E2f2329 and E2f2G5.1, and the
nearly null E2f21-188 allele, were described previously (7, 16). Rbf1120 is a hypo-
morphic allele that results from a P-element insertion in the 5 untraslated region
of the Rbf gene, whereas Rbf114 is a null deletion allele (3, 11). Dpa1 is an ethyl
methanesulfonate-induced hypomorphic Arg-to-Cys missense mutation in the
conserved DEF box (33). Df(2L)vg56 is a large deletion that uncovers the Dp
genomic region (13). The null alleles Orc23, Orc5l(2)34BG1 and ChifRA5 were
kindly provided by Mike Botchan and John Tower, respectively (23, 24). The
Mcm2rl74 allele was kindly provided by Jessica Treisman (41). For the genetic
interactions with E2f2, Orc5l(2)34BG1, and ChifRA5were recombined onto the
E2f2329 chromosome, and the recombinants were crossed to E2f21-188/CyO. In
these crosses, all E2f2 mutant females are heterozygous for Orc5 or Chif. For
Orc2 and Mcm2, males of genotype E2f21-188/;Orc23/ and E2f21-188/;
Mcm2rl74/ were mated with E2f2329/CyO females, and ovaries were dissected
from all homozygous E2f2 mutant females (identified by the lack of CyO and the
presence of w in the E2f21-188 allele). In these crosses half of the E2f2 mutants
are predicted to be heterozygous for Orc2 or Mcm2, and therefore the percent
suppression was calculated by doubling the number of egg chambers that exhibit
a suppressed phenotype. To express green fluorescent protein (GFP) specifically
in the follicle cells of E2f2 and Rbf1 mutant ovaries using the c323 GAL4 driver
(28), c323/Y; E2f2329/CyO males were mated to E2f21-188/CyO;UAS-GFP/ fe-
males and c323-Rbf14/Dp(1;Y)y2sc males were mated to Rbf120/FM7;UAS-GFP/
females, respectively. Embryos from Rbf14 germ line clones were generated as
described previously (11). E2f2-null embryos were generated by crossing
E2f2G5.1/E2f2329 P[E2f2, Mpp6] females to sibling males of the same genotype
(both of these E2f2 alleles inactivate the neighboring, essential Mpp6 gene, thus
necessitating inclusion of the P element carrying wild-type Mpp6 [7]). Even
though E2f2 homozygous mutant females have reduced fertility (7, 16), they
produce some embryos that exhibit no overt morphological defects at the stages
needed to analyze E2F-dependent gene expression. For this allele combination,
60% of the eggs hatch. A total of 418 progeny from the cross between E2f21-188/
;E2f1i2/ males and E2f2329/CyO;E2f191/TM6 females were scored for the pres-
ence of the E2f21-188/E2f2329;E2f1i2/E2f191 double mutant population. Chi-
square analysis was used to determine the level of significance of the lack of the
E2F double mutant population. E2F1336-805 was engineered by PCR of E2F1
cDNA with the primers 5-TACCTGCTCGAGGAATTCATGTCGTTGCGGC
TGGAGCAACAGGAG-3 and 5-TCGTGTGGAGGTGGCCGTACGGA
C-3 and cloned into pUAST.
BrdU labeling and in situ hybridization and immunofluorescence. Ovaries
were dissected and pulse-labeled for 1 h in Schneiders medium with bromode-
oxyuridine (BrdU) as described previously (26). Anti-BrdU antibodies (Becton
Dickinson) were detected in situ by using cyanine 3- or rhodamine-conjugated
goat anti-mouse secondary antibodies (Jackson Laboratories). DNA was stained
with DAPI (4,6-diamidino-2-phenylindole) at a final concentration of 1 g/ml
for 1 min. The extent of suppression of the E2f2 mutant follicle cell BrdU
phenotypes by Orc2, Mcm2, and E2f1 was determined by counting the numbers
of follicle cells undergoing genomic replication within a fixed area on 5 to 10
images of stage 13 egg chambers.
Embryos were collected for 4 h at room temperature, aged until the desired
stage at either 25 or 18°C, fixed in 37% formaldehyde for 5 min, and subjected
to in situ hybridization with antisense probes against Mcm3, Pcna, and RnrS
transcripts (13).
Dissected ovaries were fixed in 6% formaldehyde for 15 min for immunostain-
ing. Polyclonal rabbit anti-E2F1 (1:400) and mouse monoclonal anti-RBF1 (1:4)
antibodies were kindly provided by Nick Dyson (16, 40) and were detected with
goat anti-rabbit rhodamine (1:1,000; Molecular Probes) and goat anti-mouse
cyanine 3 (1:300; Jackson Laboratories), respectively.
Isolation and analysis of follicle cells. Follicle cells were isolated by trypsiniza-
tion and filtration of ovaries dissected from 100 females/per experiment (4, 7).
The filtration process assures that germ line cysts, which consist of nurse cells and
the oocyte interconnected by ring canals, are eliminated because they cannot
pass through the mesh. Microscopic examination of Hoechst 33342-stained,
dissociated follicle cell preparations indicated that 95% of the cells were single
cells, and therefore were not germ cells. The majority of the remaining cells were
in small aggregates of incompletely dissociated polyploid follicle cells. The rest of
the cells occur in even number aggregates that represent either diploid (i.e., 2C
and 4C) germ cell cystoblasts or follicle cells, which cannot be distinguished
microscopically. Thus, the germ cell contribution to the follicle cell preparations
is exceedingly small. Wild-type and Rbf1, E2f2, and Dp mutant females were aged
2, 2, 5, and 7 to 8 days after eclosion, respectively, before dissection in order to
obtain egg chambers from all stages of oogenesis. E2f2 and Dp mutants required
longer maturation times because oogenesis is delayed. Follicle cell ploidy was
determined by fluorescence-activated cell sorting (FACS) analysis of Hoechst
33342-stained cell preparations by using a MoFlo high-speed molecular flow
cytometer with excitation at 364 nm for Hoechst stain and at 488 nm for GFP. To
quantify mRNA levels, total follicle cell RNA prepared with Trizol reagent
(Gibco-BRL) was used in 30-l reverse transcription (RT) reactions by using the
TaqMan PCR core reagent kit (Applied Biosystems/Roche). Rp49 was amplified
simultaneously with Orc2, Orc5, or Mcm2 in a single reaction. RT-PCR consisted
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of an RT reaction at 48°C for 30 min, followed by 5 min at 95°C incubation, and
then 40 cycles of PCR performed at 95°C for 15 s and 60°C for 1 min. The
following primers and Taqman probes were used: Rp49 forward primer, 5-TG
CTAAGCTGTCGCACAAATG-3; Rp49 reverse primer, 5-CGATGTTGGGC
ATCAGATAC-3; Rp49 probe, TET 5-CGCAAGCCCAAGGGTATCGACA
AC-3 TAMRA; Orc5 forward primer, 5-GCGGATGCAGACGGTCA-3; Orc5
reverse primer, 5-AAATGGCCAGCAAACGATCG-3; Orc5 probe, FAM 5-
CGCCAGAGCCAAGACCACGGA-3 TAMRA; Orc2 forward primer, 5-CT
GGCCTCCATTGATCACAT-3; Orc2 reverse primer, 5-ATGGCAGCATTG
TTGTGCAG-3; Orc2 probe, FAM 5-CCCACCACGAGAAGTTGAAGCTG
CA-3 TAMRA; Mcm2 forward primer, 5-CCAAGCTAACGAACATCGAC-
3; Mcm2 reverse primer, 5-CCGTGGCAAAAGACTCCTGT-3; and Mcm2
probe, FAM 5-TCGCCAAGATGTCACGCCCAGCTG-3 TAMRA.
Microarray analysis. Two RNA samples prepared from follicle cells isolated
as described above were obtained from control (one E2f2329/CyO and one yw67),
E2f2 mutant (both E2f2329/E2f2329), and Rbf mutant (both Rbf14/Rbf120) fe-
males. RNA quality was assessed by nondenaturing agarose gel electrophoresis
of rRNA bands. cDNA was synthesized by using a T7-(dT)24 primer and 7 g of
total RNA (Life Technologies). Biotinylated cRNA was generated from the
cDNA by using the BioArray High Yield RNA transcript kit and subsequently
fragmented in 40 mM Tris-acetate (pH 8.1), 100 mM potassium acetate, and 30
mM magnesium acetate at 94°C for 35 min. Then, 15 g of fragmented cRNA
was hybridized to a Drosophila genome array (part 900335; Affymetrix) in 0.05 g
of fragmented cRNA/l; 50 pM control oligonucleotide B2; BioB, BioC, BioD,
and cre hybridization controls at 1.5, 5, 25, and 100 pM, respectively; 0.1 mg of
herring sperm DNA/ml; 0.5 mg of acetylated bovine serum albumin/ml; 100 mM
morpholineethanesulfonic acid; 1 M NaCl; 20 mM EDTA; and 0.01% Tween 20.
Arrays were hybridized for 16 h in a GeneChip Fluidics Station 400 and were
washed and scanned with the Hewlett-Packard GeneArray scanner. During the
washing, the cRNA probe was labeled with R-phycoerythrin streptavidin. Af-
fymetrix GeneChip microarray suite 5.0 software was used for washing, scanning,
and basic analysis. Sample quality was confirmed by examination of the 3 to 5
intensity ratios of certain genes.
Statistical analysis. The significant differences between the averages of pair-
wise comparisons of the wild type and the E2f2 and Rbf1 mutants for pre-RC
genes and replication genes in microarray experiments were determined with the
sign rank test (44). The sign rank test is nonparametric and uses both ranks and
signs of differences. To assess the significance in comparisons between genotypes
in RT-PCR experiments, an unpaired, two-tailed Student t test was applied by
using Microsoft Excel.
RESULTS
Mutation of Dp and Rbf1 causes similar ectopic follicle cell
replication phenotypes that differ from the one caused by mu-
tation of E2f2. In stage 10b and older E2f2, Dp, and Rbf1
mutant egg chambers, BrdU incorporation is detected at sites
of chorion gene amplification and also ectopically throughout
the follicle cell nuclei. We previously postulated that this ec-
topic genomic replication is caused by the loss of E2F2/DP/
RBF1 complexes (7). This was based both on the similarity in
the BrdU incorporation phenotype among these mutant folli-
cle cells (3, 7, 32) and on the observation that E2F2, DP, and
RBF1 proteins coimmunoprecipitate (3, 16, 35, 40). The iso-
lation of relatively pure populations of individual follicle cells
from trypsinized ovaries (4) allows the determination of DNA
content by flow cytometry and provides a way to evaluate the
extent of DNA replication in addition to BrdU labeling. FACS
analysis of wild-type follicle cells by this technique results in
four distinct populations ranging from 2C to 16C (Fig. 1A).
The 8C and 16C cell populations result from endocycles. In
FIG. 1. Increased ploidy in Rbf1 and Dp mutant follicle cells. Each panel contains a FACS profile of follicle cells isolated from different
genotypes. Open traces indicate total cell population. Filled traces indicate the GFP subset of the total population that was marked by using the
c323 GAL4 driver. (A) Wild-type follicle cells. Four distinct populations that represent 2C, 4C, 8C, and 16C DNA content were evaluated. In this
experiment all follicle cells are genetically c323-GAL4/ and UAS-GFP/. Because of asynchrony in endocycles, some cells attain 8C and 16C
before GFP is activated in stage 9. (B) Rbf120/Rbf14 mutant cells. (C) E2f2329/E2f2329 mutant cells. (D) Df(2R)vg56/Dpa1 mutant cells. In panels B
to C only half of the follicle cell population is genetically UAS-GFP/. Note that the 32C population is present in both Rbf1 and Dp mutants but
not in the E2f2 mutants. The 32C population in Dp mutant cells was positively identified in five independent experiments.
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some experiments UAS-GFP was expressed in these cells by
using a GAL4 driver (c323) that is activated specifically in
follicle cells beginning at stage 9 (28), allowing us to detect all
stage 9 and older follicle cells (Fig. 1A) (7). When this tech-
nique was applied to Rbf1 mutants, a 32C population of GFP
follicle cells was observed (Fig. 1B). This indicated that the
ectopic replication seen in stage 10b and older Rbf1 mutant egg
chambers by BrdU labeling results in a complete round of S
phase, as previously reported (3).
If E2F2/DP/RBF1 complexes were the only E2F complexes
that repressed genomic DNA synthesis in follicle cells, then the
replication phenotype caused by mutation of each individual
subunit should be indistinguishable by using different assays.
However, E2f2 mutants do not contain a 32C population of
follicle cells (Fig. 1B), even though the ectopic BrdU labeling
phenotype is similar to Rbf1 (see Fig. 5B) (7). What could
account for this phenotypic difference? One possibility is that
the extent of ectopic DNA synthesis in E2f2 mutants (as de-
tected by BrdU incorporation) is not as great as in Rbf1 mu-
tants and does not result in a complete, additional round of S
phase. This could occur if RBF1 is a component of two func-
tionally nonredundant repressor complexes: one containing
E2F1/DP and the other containing E2F2/DP. Accordingly,
knocking out both complexes by mutation of Rbf1 would cause
a more extensive genomic replication compared to knocking
out a single RBF1 complex by mutation of E2f2. To test this
hypothesis, we characterized follicle cells isolated from females
that were hemizygous for a viable, female sterile allele of Dp
(32). Since DP binds both E2F1 and E2F2 (16, 35), the Dp
mutant phenotype should be more like Rbf1 than like E2f2.
Indeed, a 32C population of Dp mutant follicle cells was de-
tected by flow cytometry (Fig. 1D), although the peak was not
as prominent as with Rbf1 mutants. This finding is consistent
with the observation that the Dp ectopic genomic replication
phenotype is not fully penetrant (32). These data support a
model in which both E2F1/DP and E2F2/DP form repressor
complexes with RBF1 that cooperate in suppressing the activ-
ity of nonchorion genomic replication origins after stage 10.
We attempted to corroborate our hypothesis that E2F1 and
E2F2 perform overlapping repressor roles in follicle cells by
making E2f1-E2f2 double mutants. However, the correct dou-
ble-mutant genotype was never recovered (P  0.001), even
though the individual E2f2329/E2f21-188 null and E2F1i2/E2F191
hypomorphic genotypes used are each viable on their own.
E2f191 is a null allele (14), and E2f1i2 synthesizes a truncated
protein that lacks the RBF1 interaction domain at the COOH
terminus (3). Thus, this E2f1-E2f2 allele combination is pre-
dicted to disrupt both RBF1 complexes and consequently phe-
nocopies the lethality caused by Rbf1-null alleles (11). There-
fore, the ability of RBF1 to form repressor complexes with
both E2Fs may be necessary for Drosophila development.
E2F2 acts late in follicle cell development to suppress
genomic replication. To investigate when during follicle cell
development E2F2 functions, UAS-E2F2 was expressed in
E2f2 mutant follicle cells by using the c323-GAL4 driver. In
these females, there was no evidence of ectopic genomic rep-
lication in stage 10 and older egg chambers, as assayed by
BrdU incorporation, indicating virtually 100% rescue of the
mutant phenotype (not shown). This result suggests that E2F2
acts to inhibit genomic replication when follicle cells make the
transition from endocycling to chorion gene amplification cy-
cles. If the inhibition of genomic replication requires E2F2 to
act as part of an RBF1 repressor complex, and/or other RBF1
containing complexes, then disruption of these complexes
starting at stage 9 should cause an ectopic replication phe-
notype. Disruption of RBF/E2F complexes was achieved by
overexpressing DP with a mutant E2F1 protein (E2F1336-805)
lacking the DNA-binding domain but retaining the RBF inter-
action domain. Coexpression was used because E2F/DP het-
erodimers bind RB proteins more efficiently than E2F or DP
monomers (12, 19). Coexpression of E2F1336805 and DP ac-
tivates E2F target gene expression in embryos, probably by
titrating RBF, whereas expresion of either one alone does not
(D. Lanzotti and R. Duronio, unpublished results). Expression
of E2F1336-805 and DP with c323-GAL4 in follicle cells resulted
in ectopic genomic DNA replication similar to that seen in
E2f2 and Rbf1 mutants (Fig. 2). We interpret this as an indi-
cation that disruption of RBF complexes beginning at stage 9
is sufficient to trigger ectopic genomic replication.
Genomic replication silencing in follicle cells relies on E2F-
RBF transcriptional repression. The mechanism by which E2F
transcription factors regulate the cell cycle is thought to occur
through changes in the expression of target genes (8, 15, 42).
To determine whether this plays any role in the control of
DNA synthesis in follicle cells, we analyzed the level of expres-
sion of various replication factor and pre-RC genes by using
total cellular RNA isolated from follicle cells prepared from
wild-type and E2f2, Rbf1, and Dp mutant ovaries (see Materials
and Methods). Specific mRNAs were detected by using real-
time fluorescence RT-PCR, which allows accurate quantifica-
tion of differences among independent PCR products by mea-
suring the fluorescence emitted from each DNA molecule as it
is synthesized. Mutation of E2f2 resulted in a twofold increase
in the expression of the Orc5 transcript relative to wild type
(Fig. 3A), a finding that is in agreement with our previous
results (7). In Dp and Rbf1 mutant follicle cells the amounts of
Orc5 message were approximately three- and sixfold greater,
respectively, than in the wild type (Fig. 3A). The level of Orc2
message increased approximately 2-fold in E2f2 mutants and
2.5-fold in both Dp and Rbf1 mutants (Fig. 3B). Similarly,
Mcm2 transcript levels increased 1.5-fold in E2f2, 3.5-fold in
Dp, and 4.5-fold in Rbf1 mutant follicle cells relative to the wild
type (Fig. 3C). To evaluate these differences, P values were
generated by using a Student t test (Fig. 3D). In each case the
measurements made in the mutant genotypes were signifi-
cantly different than in the wild type (P  0.05). These data
support the hypothesis that an increase in the steady-state level
of pre-RC components contributes to the appearance of ec-
topic genomic DNA synthesis in the mutants. Moreover, the
level of these transcripts were higher in Rbf1 mutants com-
pared to E2f2 (P  0.1), suggesting that both E2F1/DP/RBF1
and E2F2/DP/RBF1 repressor complexes are involved in the
proper downregulation of these genes.
To determine whether an upregulation of expression applies
to many components of the pre-RC, expression profiles were
obtained from the wild-type and from the E2f2 and Rbf1 mu-
tant follicle cells by using Affymetrix gene chips. The data are
presented in Fig. 4 as a ratio of mutant/wild-type gene expres-
sion obtained from an average of two independent experiments
for each genotype (see Materials and Methods). In general,
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pre-RC gene expression was elevated in both E2f2 and Rbf1
mutants compared to the wild type (P  0.0003 and 0.000004,
respectively). In addition, the levels of these transcripts in Rbf1
mutants were elevated compared to the E2f2 mutants (P 
0.0003). On average, Mcm and Orc gene expression was in-
FIG. 2. E2F repressor complexes act late in follicle cell develop-
ment. Each panel contains a BrdU-labeled egg chamber. (A) Stage
10 wild type; (B and C) stage 10 and stage 13 c323-GAL4/;UAS-
E2F1336-805 and UAS-DP/, respectively. See Fig. 5A for a wild-type
stage 13. The arrowheads and arrows indicate overamplification and
aberrant genomic replication in follicle cells, respectively.
FIG. 3. Orc2, Mcm2, and Orc5 transcripts are elevated in E2f2, Dp,
and Rbf1 mutant follicle cells. Relative levels of Orc5 (A), Orc2 (B),
and Mcm2 (C) transcripts were determined in wild-type and in E2f2329/
E2f2329, Df(2R)vg56/Dpa1, and Rbf 120/Rbf 14 mutant total follicle cell
RNA preparations by the TaqMan quantitative RT-PCR method. The
PCR product was quantified by determining the fluorescence intensity
at one cycle in the linear phase of the amplification. The fluorescence
values of Orc5, Orc2, and Mcm2 were compared between different
genotypes by normalizing them to the value obtained for Rp49. All
experiments were performed in triplicate, except for Orc5 in wild-type,
E2f2, and Rbf1 genotypes, which were performed four times. The data
are presented as an average of the fold increases relative to the wild
type for each of these experimental trials. (D) An unpaired, two-tailed
Student t test was used to determine level of significance of changes in
expression between different genotypes. P values for each pairwise
combination of experiments is shown.
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creased by 1.5- and 1.2-fold in E2f2 mutants and by 2.4- and
1.4-fold, respectively, in the Rbf1 mutants (Fig. 4 and Table 1).
These data correlate with the RT-PCR data, although the
magnitude of the increases as measured by the microarray
experiments is less than that measured by real-time RT-PCR.
The basis for this difference is not clear, although it could
represent differences in sensitivity between the two techniques.
Nevertheless, these data suggest that multiple genes encoding
components of the pre-RC are subject to E2F2/RBF1 tran-
scriptional repression in follicle cells, that these genes are
regulated to different degrees, and that mutation of E2f2 and
Rbf1 alter gene expression differently.
To investigate whether there was an impact on the expres-
sion of other replication factors, 49 genes encoding various
functions required for chromosome duplication during S phase
were identified from the annotated Drosophila genome data-
base, and their levels of expression were assessed by microar-
ray analysis (Table 1). As with the pre-RC subset of this group,
gene expression was in general elevated in both E2f2 and Rbf1
mutants compared to the wild type (P  0.004 and  0.0009,
respectively), and gene expression in the Rbf1 mutants was
elevated compared to E2f2 mutants (P  0.002). Of the 49
replication genes listed in Table 1, 14 genes were upregulated
by 1.5-fold in E2f2 mutants and 25 genes were upregulated
by 1.5-fold in Rbf1 mutants. Of these, 11 were upregulated by
1.5-fold in both mutants (asterisks, Table 1). The fold in-
crease in these 11 common genes ranged from 1.5 to 2.0 in
E2f2 mutants and from 1.5 to 2.8 in Rbf1 mutants. These data
indicate that replication factor gene transcription in follicle
cells is regulated by E2F2 and RBF1 and are consistent with a
model whereby the increased amounts of gene expression in
Rbf1 versus E2f2 mutants contributes to the greater severity of
the Rbf1 overreplication phenotype.
Reduction of the pre-RC gene dose suppresses ectopic
genomic replication in E2f2 mutants. The changes in replica-
tion factor gene expression detected in the E2f2 and Rbf1
mutant follicle cells were modest. To test whether small in-
creases in pre-RC gene expression could affect the regulation
of follicle cell DNA synthesis, we sought to determine whether
a 50% reduction in gene dose of certain replication factors
could suppress the ectopic genomic replication phenotype in
E2f2 mutants. To test this, BrdU incorporation was analyzed in
E2f2 mutant follicle cells that were also heterozygous for null
alleles of Orc2, Orc5, Chiffon (Dbf4), or Mcm2. Stage 13 E2f2
mutant egg chambers were scored because at this stage nearly
all follicle cells within a given egg chamber exhibit ectopic
genomic replication, and this phenotype is fully penetrant (Fig.
5A and B). Orc2 or Mcm2 heterozygosity in an E2f2 mutant
background resulted in suppression of the phenotype in 70%
of the egg chambers (Fig. 5C to F). Suppression is evidenced
by an approximate 65% reduction in the number of follicle
cells within an egg chamber that display ectopic genomic rep-
lication (Fig. 5C and F) and by an apparent reduction in the
intensity of the ectopic BrdU incorporation compared to E2f2
mutant follicle cells (Fig. 5D and F). Reduction of the Orc5
gene dose suppressed the phenotype in 36% of the stage 13
E2f2 mutant egg chambers (Fig. 5G). We were not able to
detect any obvious suppression by using mutations in Chiffon
(data not shown). These experiments suggest that inhibition of
genomic origins of replication during gene amplification cycles
is sensitive to twofold changes in the levels of ORC2, MCM2,
and ORC5.
In contrast to the results obtained with E2f2, the ectopic
genomic replication phenotype in Rbf mutant follicle cells was
not suppressed by Orc2 heterozygosity (data not shown). This
suggests that reducing the ORC2 levels by half cannot over-
come the extent of transcriptional derepression in the Rbf1
mutant and is consistent with the greater severity of the Rbf1
overreplication phenotype relative to E2f2.
Taken together, these results indicate that relatively small
changes in the amount of pre-RC components can affect rep-
lication control in follicle cells. This suggests that simple het-
erozygosity of some pre-RC components may affect DNA rep-
lication in follicle cells. To test this possibility, we examined
BrdU incorporation patterns in stage 13 Orc5/ and Orc2/
egg chambers. In both genotypes, the intensity of BrdU-la-
beled foci was slightly reduced in certain follicle cells (Fig. 5H
and I). Orc2/ replication patterns were more abnormal than
those in Orc5/ egg chambers, displaying a more obvious cy-
tological reduction in the replication of chorion gene clusters,
as well as slight genomic replication in some follicle cells.
These data further support the hypothesis that follicle cell
DNA synthesis during amplification cycles is sensitive to fairly
small changes in the cellular levels of pre-RC components.
FIG. 4. Prereplication component genes are elevated in E2f2 and Rbf1 mutant follicle cells. Each bar indicates the ratio of mutant to wild-type
hybridization signal obtained from an average of two independent experiments for each follicle cell genotype.
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E2F1 activator function stimulates the genomic replication
phenotype observed in E2f2 mutant follicle cells. In addition to
functioning in conjunction with RBF1 in transcriptional re-
pression, E2F1 also acts to stimulate replication factor gene
expression when not bound to RBF1. Therefore, two factors
could influence the extent of ectopic genomic replication in
E2f2 mutant follicle cells. The first is loss of E2F2/DP/RBF1
repressor complexes, and the second is activation mediated by
E2F1/DP complexes. If the E2f2 ectopic replication phenotype
requires input from E2F1-mediated activation, then reducing
the level of E2F1 function may suppress the phenotype. BrdU
labeling revealed that 55% of stage 13 E2f2 mutant egg cham-
bers that were also heterozygous for a E2f1 null allele con-
tained 50% reduction in the number of follicle cells exhibit-
ing ectopic genomic replication compared to E2f2 mutants
(Fig. 6). This suggests that a shift in the endogenous complexes
toward formation of E2F1/DP activators might be contributing
to the E2f2 mutant phenotype by stimulating the transcription
of replication genes in the absence of functional E2F2/DP/
RBF1 repressor complexes. An increase in the level of E2F1
protein in E2f2 mutant follicle cells does not appear to con-
tribute to this shift, since the level of E2F1 protein detected by
immunostaining of whole egg chambers appeared indistin-
guishable between wild-type and E2f2 mutant follicle cells
(data not shown).
Developmental differences in the action of E2F1 and E2F2
repressors. To determine whether E2F1 and E2F2 repressor
activities cooperate at other times or in other tissues during
development, the expression of E2F target genes was analyzed
during embryogenesis. RnrS and Pcna are both expressed in
late embryos coincidentally with replicating cells in a pattern
that results from activation and repression mediated by E2F1
and RBF1 (Fig. 7A and C). In E2f1 and Dp mutant embryos,
the expression of these two genes is lost (13, 14, 33) and, in
embryos lacking Rbf1, both are hyperactivated (11) (shown for
Pcna in Fig. 7L). Consequently, whereas E2F1 provides acti-
vator function for these two genes in the embryo, the repres-
sion of these genes is not affected by mutation of E2f1. To
determine the contribution of E2F2, we generated embryos
lacking both maternal and zygotic E2f2 (see Materials and
Methods). Both the RnrS and Pcna expression pattern ap-
peared similar between E2f2 mutant and wild-type embryos
(Fig. 7B and D). The same result was obtained with Mcm2 (not
shown). These data suggest that in the embryo E2F1 can alone
provide both activation and repression activities for these
genes in the absence of E2F2.
We previously observed that Mcm3 expression is dere-
pressed in Dp mutant embryos in quiescent cells of the central
nervous system (CNS) but not in quiescent epidermal cells
(13). Both the loss of E2f2 (Fig. 7E and F) and the loss of Rbf1
(Fig. 7G and H) function cause a Mcm3 derepression pheno-
type in the CNS similar to Dp mutants, suggesting that an
E2F2/DP/RBF1 complex participates in Mcm3 repression
here. Because E2f1 is required for embryonic Mcm3 expression
in the CNS (13), this result suggests that for some genes in the
embryo E2F1 and E2F2 do not act redundantly, as is the case
in follicle cells. Interestingly, the loss of Rbf1 causes detectable
ectopic Mcm3 expression in the epidermis (Fig. 7I and J),
although it is not as obvious as with Pcna (Fig. 7K and L). Since
neither mutation of E2f1 or E2f2 causes ectopic epidermal
expression of these genes, these data suggest that E2F1 and
E2F2 act redundantly as repressors in this tissue. Therefore,
the extent to which E2F1 and E2F2 act redundantly or coop-
eratively as repressors is tissue specific.
TABLE 1. Replication genes are derepressed in


















dup (CBT1) 1.3 2.0
chif (DBF4) 1.0 0.8
CDC45L 0.9 1.2
Replication factors
awd (NDP kinase) 0.9 0.9
Dhfr 1.0 1.2
deoxynucleoside kinase (dnk) 1.1 2.9
nmdyn-D6 (NDP kinase) 0.7 0.6




PCNA (mus209) 1.1 2.2
CG10262 (PCNA2) 0.5 0.6
CG8142 (RfC) 1.6 1.6


























a The data are presented as a ratio of mutant to wild-type hybridization signals
obtained from an average of two independent DNA microarray experiments for
each follicle cell genotype. Genes that exhibited a 1.5-fold increase in both
E2f2 and Rbf1 mutant follicle cells are indicated by an asterisk.
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DISCUSSION
The relative contribution of the E2F activator versus repres-
sor functions to cell cycle control in specific tissues during
development is not completely understood. Previous data have
suggested that Drosophila E2F1 primarily functions as an ac-
tivator and that E2F2 functions as a repressor of transcription
and consequently cell cycle progression (7, 16). Here we pro-
vide evidence that E2F1 and E2F2 are both required in ovarian
follicle cells to repress transcription and inhibit DNA synthesis
and therefore can also function in a similar way. Moreover, our
analysis indicates that the requirements for E2F1 and E2F2 in
embryos are not the same in every tissue.
During oogenesis follicle cells execute a complex cell cycle
program that includes canonical mitotic cycles, endocycles, and
finally chorion gene amplification (38). Chorion gene amplifi-
cation requires two types of regulation: (i) the repeated firing
of replication origins within chorion gene clusters and (ii)
prevention of replication initiation at other genomic origins.
Genes known to affect the first process encode components of
the replication initiation complex (ORC proteins, Chiffon, and
MCMs) (23, 24, 36), as well as E2F1, DP, and RBF1, which are
likely bound to chromatin near chorion origins and regulate
gene amplification independently of transcription (3, 33). The
second process is also under E2F regulation, and mutations in
E2f2, Dp, or Rbf1 result in ectopic genomic replication in
follicle cells at a stage when only chorion origins should be
active (3, 7, 33). However, genomic replication is more exten-
sive in Rbf1 and Dp mutant follicle cells, which attain a 32C
DNA content, than in E2f2 mutants, which do not. One pos-
sible explanation for this difference is that the complete inac-
tivation of genomic replication is achieved by the cooperative
activity of E2F2/DP/RBF1 and E2F1/DP/RBF1 repressor com-
plexes. E2f2 loss of function disrupts only one of these com-
plexes, whereas the loss of Rbf1 or Dp disrupts both. There-
fore, the presence of E2F1 containing repressor complexes
constrains the extent of overreplication in the E2f2 mutant
cells. Since in mammalian cells E2Fs can regulate pRB levels
(8, 15), another possibility is that loss of E2f2 causes an in-
crease in the level of RBF1 protein, thereby driving the for-
mation of more E2F1/RBF1/DP repressor complexes and
making the E2f2 mutant phenotype less severe than Rbf or Dp.
However, we consider this unlikely since there was no detect-
able difference in RBF1 immunostaining of E2F2 mutant fol-
licle cells compared to wild type (not shown). The same result
was obtained by immunoblotting of protein extracts from wild-
type or E2f2 mutant larvae (40).
A large body of evidence indicates that the mechanism by
which E2F complexes control DNA replication is via transcrip-
tion (8, 15). Here and in our previous report (7) we demon-
strate that E2f2 mutant follicle cells contain a two- to threefold
increase in transcripts encoding pre-RC proteins such as Orc2,
Orc5, and Mcm2 relative to wild type. This small increase
appears to be significant, as a reduction of one functional copy
of the Orc2, Orc5, or Mcm2 gene substantially suppressed the
incidence of ectopic genomic replication in E2f2 mutant folli-
cle cells. This suggests that increases in the levels of pre-RC
components in the absence of E2F/RB repressors may increase
the number of active origins, thereby causing ectopic DNA
synthesis. In vitro studies have shown that activation of mam-
malian replication origins is sensitive to the ratio of initiation
factors to DNA substrate, which in turn could regulate the
number of origins activated (25). Previous cytological observa-
tions made by immunodetection of pre-RC subunits also sup-
port this model. In wild-type ovaries, ORC subunits are de-
tected throughout the follicle cell nucleus during endocycles
but are subsequently localized to chorion loci during gene
amplification (33). In contrast, ORC proteins are not localized
to sites of gene amplification in E2f2, Dp, and Rbf1 mutant
follicle cells but are found throughout the nucleus (3, 7, 32).
This suggests that pre-RC protein levels are inappropriately
elevated. Similarly, a twofold increase in ORC1 protein levels
is sufficient to cause mislocalization throughout the nucleus
during gene amplification stages and also results in genomic
replication (1). Taken together, these data suggest that tran-
scriptional inhibition of pre-RC genes by both E2F/DP/RBF1
and E2F2/DP/RBF1 complexes contributes to the proper re-
striction of DNA synthesis to sites of gene amplification. The
E2f2 replication phenotype is completely rescued by initiating
FIG. 6. Suppression of E2f2 mutant follicle cell cycle phenotype by mutations in E2f1. Both panels contain a stage 13 egg chamber pulse-labeled
with BrdU. (A) E2f2329/E2f21-188 mutant; (B) E2f2329/E2f21-188; E2f91/ mutant. The arrow indicates a follicle cell with a reduced level of BrdU
incorporation compared to E2f2 mutants.
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FIG. 7. E2F1 and E2F2 repressors primarily act redundantly during embryogenesis. Each panel contains a germ band retracted embryo subject
to in situ hybridization with the indicated probe. Anterior is at left, and dorsal at the top. (A, C, and E) Wild-type embryos. Panels A and C contain
embryos at different stages in order to show two different representative patterns of the replication-asssociated gene expression program. (B, D,
and F) Embryos lacking both maternal and zygotic E2f2. Note that the pattern of expression is identical to that of the wild type for RnrS and Pcna
but not for Mcm3, which is derepressed in the CNS (arrows). The embryos in panels E and F are rotated slightly to the ventral surface. (G, I, and
K) Phenotypically normal sibling control embryos of those shown in panels H, J, and L, respectively. (H, J, and L) Embryos lacking maternal and
zygotic Rbf1 function. The focal plane in panels I to L is at the epidermis, rather than the interior tissues as in panels A to H, in order to show
the ectopic expression in this tissue.
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expression of wild-type E2F2 at stage 9, suggesting that E2F2
can exert its effect just prior to the onset of chorion gene
amplification. Consequently, the downregulation of transcrip-
tion must result in a decrease of pre-RC proteins below a
threshold necessary to support genomic replication between
stages 9 and 10 (6 h).
Contrasting and overlapping roles for E2F family members
during Drosophila development. Recent experiments have in-
dicated that E2F1 and E2F2 functionally oppose one another
rather than act similarly (16). First, overexpression of E2F2
suppresses the rough eye phenotype caused by overexpression
of E2F1. Second, E2f1 and E2f2 double mutants progress to a
later stage of development (pupae) than do E2f1 single mu-
tants (larvae), indicating that E2F2 contributes to the earlier
lethality of E2f1 mutants. How can these results be reconciled
with our observation in follicle cells? One possibility is that
E2F2 acts as a dedicated repressor and is never an activator,
whereas E2F1 can function as both an activator and a repres-
sor. In this scenario, E2F2 can both antagonize E2F1 activator
function and act redundantly with E2F1 for repression. The
relative contribution of these interactions to gene expression
and cell cycle control will depend on the genes being analyzed
and the developmental context.
This model is supported by our analysis of different tissues.
A dual role for E2F1 is evident in the follicle cells, where the
reduction of the E2f1 gene dose in an E2f2 mutant background
partially suppressed the ectopic replication phenotype, repre-
senting a positive contribution to replication by E2F1/DP. In
the embryo, the replication-associated pattern of RnrS and
Pcna expression requires E2f1, Dp, and Rbf1 but not E2f2.
Because a second Drosophila pRB homolog called RBF2 only
binds to E2F2 (40), the simplest interpretation is that the
activation and repression of transcription responsible for this
pattern is predominantly generated by E2F1 complexes. More-
over, the fact that RBF1 loss causes derepression of RnrS,
Pcna, and Mcm3 in the epidermis but mutation of either E2f1
or E2f2 alone does not suggests that E2F1 and E2F2 can act
redundantly to repress these genes in the embryo. This is
consistent with biochemical data indicating that RBF1 coim-
munoprecipitates with both E2F1 and E2F2 (16, 40). A similar
redundancy in the inhibitory activities of E2F-1 and E2F-2 in T
cells (46) and of E2F-4 and E2F-5 in embryonic fibroblasts (17)
also occurs in the mouse.
Interestingly, redundancy between E2F1 and E2F2 repres-
sion of Mcm3 does not occur in all embryonic tissues. Mcm3
transcription is derepressed in the CNS of E2f2, Dp, and Rbf1
mutant embryos but not in E2f1 mutant embryos (13). These
gene-specific requirements for the functions of various E2F
complexes may reflect differences in how the cell cycles are
controlled during development. That is, although the follicle
cells rely on inhibiting pre-RC gene expression for replication
control, this mode of regulation is not necessary for embryonic
cell cycle control, including in the CNS. Thus, the relative
contributions of individual E2F repressor and activator func-
tions to gene expression and cell cycle regulation depend on
the developmental context.
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